Mangoceuticals Inc. has acquired IP assets from Smokeless Technology Corp., aiming to establish a foothold in the growing oral stimulant pouch sector.

Target Information

ArcStone Securities and Investments Corp. serves as the exclusive financial advisor to Mangoceuticals Inc. (NASDAQ: MGRX) in its acquisition of intellectual property (IP) assets and technology from Smokeless Technology Corp. ("Smokeless Tech"), a Canadian innovator specializing in stimulant-based pouches and functional wellness delivery systems. This strategic acquisition aims to enhance Mangoceuticals' capabilities in the growing oral stimulant pouch market, leveraging Smokeless Tech's proven formulations and distribution relationships.

With a strong executive team, including Tim Corkum, a veteran with extensive experience at Philip Morris International, the new Pouch Division aims to commercialize and expand the product lineup. The acquisition allows Mangoceuticals to tap into multiple consumer segments, including athletes and health-conscious individuals, utilizing modern delivery methods that appeal to the younger demographic seeking alternatives to traditional nicotine products.

Industry Overview

The oral stimulant pouch sector is rapidly evolving, driven by increasing consumer demand for convenient and healthier alternatives to traditional smoking and nicotine consumptio